Literature DB >> 22609074

Synthesis and evaluation of N(1)-alkylindole-3-ylalkylammonium compounds as nicotinic acetylcholine receptor ligands.

Edwin G Pérez1, Bruce K Cassels, Christoph Eibl, Daniela Gündisch.   

Abstract

In this study thirty-three novel indole derivatives were designed and synthesized based on the structure of deformylflustrabromine B (1), a metabolite isolated from the marine bryozoan Flustra foliacea L. The syntheses were carried out using standard methodologies and in good yields. The molecules were tested for their affinities for the α4β2(∗), α3β4(∗), α7(∗) and (α1)(2)β1γδ nicotinic acetylcholine receptor (nAChR) subtypes. Binding assays showed that, among these ligands, compound 7c exhibited the highest affinity with K(i)=136.1, 93.9 and 862.4nM for the α4β2(∗), α3β4(∗), and α7(∗) nAChRs subtypes, respectively. These results indicated that the indole core might be a useful scaffold for the development of new potent and selective nAChR ligands.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609074     DOI: 10.1016/j.bmc.2012.04.050

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  The potential of achiral sponge-derived and synthetic bromoindoles as selective cytotoxins against PANC-1 tumor cells.

Authors:  Nicholas Lorig-Roach; Frances Hamkins-Indik; Tyler A Johnson; Karen Tenney; Frederick A Valeriote; Phillip Crews
Journal:  Tetrahedron       Date:  2017-11-14       Impact factor: 2.457

2.  Synthesis of β-alkoxy-N-protected phenethylamines via one-pot copper-catalyzed aziridination and ring opening.

Authors:  Jorge Saavedra-Olavarría; Matías Madrid-Rojas; Iriux Almodovar; Patricio Hermosilla-Ibáñez; Edwin G Pérez
Journal:  RSC Adv       Date:  2018-08-06       Impact factor: 4.036

3.  Methylpiperidinium Iodides as Novel Antagonists for α7 Nicotinic Acetylcholine Receptors.

Authors:  Jhon J López; Jesús García-Colunga; Edwin G Pérez; Angélica Fierro
Journal:  Front Pharmacol       Date:  2018-07-10       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.